GOTHENBURG, Sweden, Jan. 20, 2026 /PRNewswire/ — Vitrolife AB (publ) will publish its fourth quarter and full year report 2025 on Tuesday, 3 February 2026 at 08GOTHENBURG, Sweden, Jan. 20, 2026 /PRNewswire/ — Vitrolife AB (publ) will publish its fourth quarter and full year report 2025 on Tuesday, 3 February 2026 at 08

Invitation to Vitrolife Group’s presentation of the fourth quarter and full year report 2025

GOTHENBURG, Sweden, Jan. 20, 2026 /PRNewswire/ — Vitrolife AB (publ) will publish its fourth quarter and full year report 2025 on Tuesday, 3 February 2026 at 08:00 am CET. A conference call for investors, analysts and financial media will be held at 10:00 am CET the same day. 

The presentation will be held in English by Bronwyn Brophy O’Connor, CEO, and Pär Ihrskog, CFO. The conference call will begin with a presentation of the report followed by a question-and-answer session. The presentation material will be available prior to the start of the conference call on the Vitrolife Group website www.vitrolifegroup.com. 

To follow the webcast, please use this link.  

To participate in the conference call please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference. 

After the event, the presentation material and a recording of the webcast will be available at www.vitrolifegroup.com.  

Gothenburg, 20 January 2026 
VITROLIFE AB (publ) 

CONTACT:

Contact:
Amelie Wilson, Investor relations, external corporate communications and executive support, awilson@vitrolife.com

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab–publ-/r/invitation-to-vitrolife-group-s-presentation-of-the-fourth-quarter-and-full-year-report-2025,c4294815

Cision View original content:https://www.prnewswire.com/news-releases/invitation-to-vitrolife-groups-presentation-of-the-fourth-quarter-and-full-year-report-2025-302665660.html

SOURCE Vitrolife AB (publ)

Market Opportunity
Newton Logo
Newton Price(AB)
$0.002788
$0.002788$0.002788
-0.32%
USD
Newton (AB) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
Stellar (XLM) Price Analysis for February 1

Stellar (XLM) Price Analysis for February 1

The post Stellar (XLM) Price Analysis for February 1 appeared on BitcoinEthereumNews.com. The crypto market keeps reaching new local lows, according to CoinStats
Share
BitcoinEthereumNews2026/02/02 05:21
PEPE Price Prediction: Meme Coin Targets Recovery Despite Technical Weakness

PEPE Price Prediction: Meme Coin Targets Recovery Despite Technical Weakness

The post PEPE Price Prediction: Meme Coin Targets Recovery Despite Technical Weakness appeared on BitcoinEthereumNews.com. Timothy Morano Feb 01, 2026 16:58
Share
BitcoinEthereumNews2026/02/02 05:00